T-cell-rich B-cell lymphoma: Analysis of clinical features, response to treatment, survival and comparison with diffuse large B-cell lymphoma

Oncology

Volumn 61, Issue 4, 2001, Pages 257-264

  Tsirigotis, Panagiotis ^a   Economopoulos, Theofanis ^a,b   Rontogianni, Dimitra ^a   Dervenoulas, John ^a   Papageorgiou, Efstathios ^a   Bollas, Georgios ^a   Mantzios, Georgios ^a   Kalantzis, Dimitris ^a   Koumarianou, Anna ^a   Raptis, Sotirios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

B cells; Diffuse large cell lymphoma; Survival; T cell rich B cell lymphoma

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; LACTATE DEHYDROGENASE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; CELL SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; T LYMPHOCYTE; TREATMENT OUTCOME;

AGED; ANTIGENS, CD; ANTIGENS, CD20; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; MITOXANTRONE; NEOPLASM STAGING; PREDNISOLONE; PREDNISONE; RETROSPECTIVE STUDIES; SPLEEN; SURVIVAL RATE; T-LYMPHOCYTES; TIME FACTORS; VINCRISTINE;

EID: 17944361918     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055331     Document Type: Article

References (20)

1. T-cell-rich B-cell lymphomas. A clinicopathological study of 19 cases
2. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkins disease
3. T-cell-rich B-cell lymphoma
4. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
5. Proposed World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues
6. Differential diagnosis between classic Hodgkins lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry
7. T-cell-rich B-cell lymphoma. What is new? What is cool?
8. Report of an International Workshop to standardize response criteria for non-Hodgkin's lymphomas
9. A predictive model for aggressive non-Hodgkins lymphoma
10. Diffuse B cell lymphomas with T cell predominance in patients with follicular lymphoma or 'pseudo T cell lymphoma'
11. T-cell rich B-cell lymphoma
12. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness
13. Large B-cell lymphoma with a high content of reactive T cells
14. T-cell-rich B-cell non-Hodgkins lymphoma mimicking Hodgkins disease
15. T-cell-rich large B-cell lymphoma in children and adolescents. A clinicopathologic report of six cases from the Children's Cancer Group Study CCG-5961
16. Differential diagnosis between classic Hodgkin's lymphoma. T-cell rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry
17. T-cell-rich B-cell lymphoma. A clinicopathological study of eight cases
18. Bone marrow involvement in T-cell-rich B-cell lymphoma
19. CHOP versus CNOP (N = mitoxantrone) in non-Hodgkin's lymphoma: An interim report comparing efficacy and toxicity
20. Treatment of intermediate and high grade non-Hodgkin's lymphoma using CEOP versus CNOP